Lupin Stock Analysis
About Lupin
Lupin is an Indian pharmaceutical company specializing in generics, complex generics, and branded formulations with global presence.
Business Model
- Generic drug manufacturing
- Branded formulations
- Specialty & complex generics
- Global exports
Strengths
- Strong US market exposure
- Growing specialty pipeline
- Research & development focus
- Improving operational efficiency
Risks
⚠ USFDA regulatory risks
⚠ Pricing pressure in generics
⚠ Currency fluctuations
Conclusion
Lupin offers growth opportunities in specialty generics, though regulatory and pricing challenges remain key risks.